Please login to the form below

Not currently logged in
Email:
Password:

lampalizumab

This page shows the latest lampalizumab news and features for those working in and with pharma, biotech and healthcare.

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway. Lampalizumab in phase III for age-related maculardegeneration. ... Roche has started enrolling patients into phase III trials of lampalizumab for dry age-related macular degeneration (AMD) - a major

Latest news

  • Roche moves eye drug lampalizumab into phase III Roche moves eye drug lampalizumab into phase III

    Roche moves eye drug lampalizumab into phase III. It could be the first treatment for geographic atrophy. ... Sandra Horning, head of global product development and chief medical officer at Roche, said: “ Lampalizumab has the potential to represent a

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics